Tradestie Institutional Equity Comparison Engine

PRLD vs CING โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CING Overall Edge

CING Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cingulate Inc. Common Stock (CING) driven by superior Growth & Margin, Options & Structure while PRLD counters with relative strength in Momentum & Technical. Fundamentally, PRLD trades at N/M Forward P/E with -294.8% operating margin (+41.0% YoY revenue) versus CING at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PRLD sits in BREAKDOWN (43rd %ile IV; Dealer Gamma Walls on Pro) against CING sits in BREAKDOWN (16th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
PRLD N/M vs CING N/M Fwd P/E
Growth & Margin Winner CING
Op Margin -294.8% vs 0.0% ยท YoY +41.0% vs +0.0%
Momentum & Technical Winner PRLD
1Y +116.8% vs +35.4% ยท 52W Pos 36% vs 18%
Options & Structure Winner CING
BREAKDOWN (43rd %ile IV) vs BREAKDOWN (16th %ile IV)
PRLD NASDAQ
Prelude Therapeutics Incorporated
Pharmaceutical Preparations
$3.29
-3.37% 1D
Market Cap $275.3M
1M Return -2.8%
1Y Return +116.78%
Forward P/E N/M
Unified AI Score
47.5 / 100 HOLD
Tech 34.0 Fund 55.0 Flow 67.0 Mom 74.0
CING NASDAQ
Cingulate Inc. Common Stock
Pharmaceutical Preparations
$4.72
+26.0% 1D
Market Cap $62.5M
1M Return +8.37%
1Y Return +35.39%
Forward P/E N/M
Unified AI Score
44.8 / 100 HOLD
Tech 31.0 Fund 50.0 Flow 67.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PRLD +116.78% CING +35.39% Spread: +81.39 pp (PRLD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PRLD TTM Op. Margin: -294.8% CING TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PRLD vs CING. Trailing 12-month operating profitability (PRLD -294.8% vs CING 0.0%) and valuation multiples (PRLD N/M vs CING N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PRLD (6) vs CING (2)
Institutional Metric PRLD CING Criterion Row Winner
Market Capitalization Scale $275.3M $62.5M Larger Scale PRLD
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +41.0% +0.0% Higher Growth PRLD
Operating Margin (TTM) Profitability -294.8% 0.0% Higher Margin CING
Net Profit Margin Profitability -269.8% 0.0% Higher Margin CING
Return on Equity (ROE) Capital Efficiency -57.7% -198.7% Higher ROE PRLD
52-Week Range Position Momentum 36% ($1โ€“$7) 18% ($3โ€“$12) Stronger Trend PRLD
Beta / 30D Volatility Risk Regime 2.02ฮฒ ยท 74% Vol 1.07ฮฒ ยท 121% Vol Lower Realized Risk PRLD
Unified Institutional Score Composite Signal 47.5 / 100 (HOLD) 44.8 / 100 (HOLD) Higher Composite PRLD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PRLD vs CING Buy Guide
PRLD BREAKDOWN
150d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live PRLD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CING BREAKDOWN
170d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live CING Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PRLD nor CING registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.